3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
26
Brain Neoplasms
23
Lung Neoplasms
17
Neoplasm Metastasis
15
Breast Neoplasms
12
Melanoma
9
Carcinoma, Renal Cell
8
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
4
Urinary Bladder Neoplasms
3
Neoplasms
3
NSCLC
3
Meningioma
3
Gastrointestinal Neoplasms
3
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Epidural Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
fludarabine
2
durvalumab
2
Cyclophosphamide
2
ruxolitinib
1
repotrectinib
1
ponatinib
1
pembrolizumab
1
gilteritinib
1
fludarabine phosphate
1
cemiplimab
1
atezolizumab
1
Whole-Body Irradiation
1
Tacrolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Immunotherapy
1
Idarubicin
1
Granulocyte Colony-Stimulating Factor
1
Docetaxel
1
Cytarabine
1
Cisplatin
1
CPI-0610
1
Busulfan
1
Bone Marrow Transplantation
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Radiosurgery
×
90 days
×
Clear all
No trials found.